Professional Documents
Culture Documents
AAIC 2012
Premiere conference in Alzheimers disease Vancouver 2012: over 4,300 scientists; 65 countries Highlights from 2012:
Risk and risk management of Alzheimers Possible early warning signs of Alzheimers disease Therapy development advances Possible prevention of Alzheimers
WW-ADNI
C-ADNI
B-ADNI
ArgADNI
A-ADNI
More Information:
alz.org/research/funding/global_biomarker_projects.asp
10
11
Alzhiemers Association Quality Control Program for CSF biomarkers (ELISA, xMAP, MSD) $1 million
MSD, Innogenetics, Saladax Biomedical, OCD and Roche Diagnostics IRMM, one of 7institutes of the Joint Research Centre of the European Commission, has made a formal decision to assist in the development of reference materials for CSF A42.
13
GBSC working group in May of 2012 Goal of developing international reference materials for CSF AD biomarkers and to establish reference methods. IRMM will supervise the projects and perform feasibility analyses. Best candidate methods and materials will be submitted to IFCC for certification. Certified reference materials will undergo large scale production by IRMM who will store and provide the material to assay manufacturers.
14
CADRO/ IADRP
CADRO (Common Alzheimer Disease Research Ontology): collaborative effort between the National Institute on Aging (NIA) and the Alzheimers Association (AA). Unified classification system to enable comparative analysis of research portfolios, strategic planning, and coordination by federal and non-federal agencies supporting AD research in the United States and internationally. IADRP: International Alzheimers Disease Research Portfolio including international funders that support AD research
15
Funded $100,000
18
19
Unprecedented database
Provide researchers worldwide with free-ofcharge access to a vast repository of data
Sophisticated analytical tools; massive computational power to ask complex questions $5 million
20
21
alz.org
22